UNSPSC 51143801: Amphetamine/dextroamphetamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN801. This VA Drug Class (CN801) classifies this compound as belonging to the group AMPHETAMINES.

UNSPSC 51143801 Amphetamine/dextroamphetamine is a Commodity code that in recent state and local practice encompasses pharmaceutical procurement across a spectrum of products and delivery models, though the code's nominal scope does not map cleanly to the opportunities now being solicited under it. Recent opportunities show state and local buyers seeking emergency response medications, generic pharmaceuticals through cooperative arrangements, and direct-to-manufacturer prescription programs — a scope that extends well beyond the single active ingredient implied by the code name. Issuing bodies include county health departments (Seminole County, Florida), state health commissions (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The Florida and Minnesota procurements represent operational demand from established buyers in the health and safety space, while the Texas RFI signals exploratory market engagement at the state level around pharmacy program modernization.

The most recent activity concentrates in Florida, Texas, and Minnesota. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, Sanford, with a response deadline of July 26, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription contracting outside traditional pharmacy benefit manager and group purchasing organization arrangements. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, with a proposal due date of March 26, 2026, and contract effectiveness set for July 1, 2026. The code shows limited but active state and local procurement velocity, though the mismatch between the code's narrow chemical name and the breadth of pharmaceutical products actually being sourced suggests potential tagging or catalog maintenance inconsistency in the source systems.